Metabolically healthy obesity (MHO) is not a stable state—rather, it's a slippery slope toward metabolic syndrome and increased risk of cardiovascular disease (CVD), suggests a long-term study published April 23 in the Journal of the American College of Cardiology.

Children whose families have increased psychosocial risks are three times more likely to discontinue weight management treatment and are also less likely to improve their weight status, according to new research published April 5 in the Journal of Pediatrics.

Though research shows that fathers impact their children’s eating habits and physical activity, a study published April 10 in Preventive Medicine suggests fathers are rarely included in family interventions that combat childhood obesity.

A class of blood pressure medications—short-acting calcium channel blockers (CCBs)—was associated with an increased risk of pancreatic cancer in postmenopausal women, according to a study presented April 17 at the American Association for Cancer Research (AACR) Annual Meeting in Chicago.

A team of researchers from Geisinger Health System in Pennsylvania are attempting to curb diabetes among their patient population with a program that treats healthy food like a prescription drug—and it has delivered strong early results.

Doctors have a new ally in keeping their patients adherent to cardiovascular medication: a urine test that can determine whether a person has taken 80 different blood pressure or cholesterol drugs in the last day or two.

New research in the New England Journal of Medicine April 5 suggests a reduction in body mass index (BMI) before puberty may decrease an individual’s risk of developing diabetes.

Both high and low concentrations of HDL cholesterol are associated with higher risks of infectious disease including gastroenteritis and pneumonia, according to new research published April 7 in the European Heart Journal.